Persson I, Adami H O, Lindberg B S, Johansson E D, Manell P
Acta Obstet Gynecol Scand. 1983;62(4):297-302. doi: 10.3109/00016348309156225.
A cohort of 23 233 women who had received estrogen prescriptions was recruited for a prospective study of estrogen therapy and the associated risk of endometrial cancer. For a detailed study, a comprehensive questionnaire was mailed to 735 randomly sampled cohort members, and 89 per cent of them responded. Estrogen exposure and its implications were described in a preceding paper (part I). The present paper reports the distribution in the cohort sample of personal features known to be risk factors for endometrial cancer. A comparison with results from various materials derived from population-based surveys and case-control studies implied that the cohort members might have a lower proportion of nulliparity (infertility) and a somewhat higher prevalence of hypertension. Differences in the distributions of age at menarche or menopause, weight, height and prevalence of diabetes were according to these comparisons slight and probably without clinical significance. It was concluded that the prevalence of risk factors for endometrial cancer other than estrogen exposure was not higher in the cohort than in the background population. Moreover, approximately one-fifth of the estrogen takers had been freed of their risk through hysterectomies.
招募了一组23233名接受过雌激素处方的女性,进行雌激素治疗及相关子宫内膜癌风险的前瞻性研究。为进行详细研究,向735名随机抽取的队列成员邮寄了一份综合问卷,其中89%的人进行了回复。雌激素暴露及其影响在之前的一篇论文(第一部分)中已有描述。本文报告了已知为子宫内膜癌风险因素的个人特征在队列样本中的分布情况。与基于人群的调查和病例对照研究得出的各种材料的结果进行比较表明,队列成员的未生育(不育)比例可能较低,高血压患病率略高。根据这些比较,初潮或绝经年龄、体重、身高以及糖尿病患病率的分布差异较小,可能无临床意义。得出的结论是,除雌激素暴露外,子宫内膜癌风险因素在队列中的患病率并不高于背景人群。此外,约五分之一服用雌激素的人通过子宫切除术消除了风险。